Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676806 · ClinicalTrials.gov registry record · Phase 2
A Phase II Study of Umbilical Cord Blood Transplantation
A Phase 2 study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00676806 is a Phase 2 study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT00676806, a Phase 2 study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study is designed to determine whether Umbilical Cord Transplantation (UCB) can be substituted for adult bone marrow cells in the standard stem cell transplant regimens used at this hospital for subjects who do not have stem cell donors.
Interventions
- BIOLOGICAL Umbilical Cord Blood After Myeloablative Conditioning
- BIOLOGICAL Umbilical Cord Blood After Reduced-Intensity Conditioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2005-07 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676806
The ClinicalTrials.gov registry entry for NCT00676806 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Umbilical Cord Blood After Myeloablative Conditioning is the first listed.
NCT00676806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00676806 about?
NCT00676806 is a clinical study titled "A Phase II Study of Umbilical Cord Blood Transplantation". This study is designed to determine whether Umbilical Cord Transplantation (UCB) can be substituted for adult bone marrow cells in the standard stem cell transplant regimens used at this hospital for subjects who do not have stem cell donors.
What is the current status of trial NCT00676806?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2005-07. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00676806?
The interventions under investigation include: Umbilical Cord Blood After Myeloablative Conditioning (BIOLOGICAL), Umbilical Cord Blood After Reduced-Intensity Conditioning (BIOLOGICAL).
Who is sponsoring clinical trial NCT00676806?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.